Roy S. Rubinfeld,Raymond A. Hartman,Sandy T. Feldman
申请号：
US14387803
公开号：
US09566301B2
申请日:
2013.03.28
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Methods and compositions for treating various indications by lessening oxidative stress in a patient are provided. A pharmaceutical composition comprises between about 0.001% to about 10.0%), or more specifically between about 0.015% to about 5%, sodium iodine or catalase by weight. The iodine ion or the catalase dissociates hydrogen peroxide into water and molecular oxygen to interrupt biological events that result in negative side effects. The pharmaceutical composition further comprises in some cases a reducing agent or various carrier materials. The pharmaceutical composition is in some cases formulated for a variety of delivery methods.
